Yoshifumi Naka, M.D., PhD

Annabel Endean, NP, is a dedicated Nurse Practitioner specializing in the diagnosis and management of gastroesophageal reflux disease (GERD) and hiatal hernias. With a focus on evidence-based assessments and personalized treatment plans, she aims to optimize patient outcomes and improve overall quality of life. Collaborating with a multidisciplinary team, Annabel emphasizes a patient-centered approach that includes education and empowerment, guiding patients to make informed decisions about their care. Her expertise encompasses a range of gastrointestinal disorders, ensuring comprehensive care that addresses both acute and chronic aspects of these conditions. Generated from the website

Christopher Comstock, MD is a Board-Certified radiologist specializing in Breast Imaging. He is an Assistant Professor of Clinical Radiology at Weill Cornell Medicine and an Assistant Attending Radiologist at the NewYork-Presbyterian Hospital-Weill Cornell Campus.Dr. Comstock graduated from the University of San Diego where he earned his B.A. in 1986. He then received his M.D. from the Tulane University Medical School in 1990.Following an internship at Ochsner Clinic and Foundation, Dr. Comstock completed his residency in Radiology from 1991 to 1995 at Ochsner Clinic and Foundation. He then completed his fellowship in Breast Imaging from 1995 to 1996 at University of Chicago.After twenty-eight subsequent years in clinical practice, Dr. Comstock joined the faculty at Weill Cornell Medicine in September 2024 as an Assistant Professor of Clinical Radiology.Dr. Comstock is a member of the following radiological societies:• American Roentgen Ray Society• American College of Radiology• Society of Breast Imaging• Radiological Society of North America• UCSD Moores Cancer Center• San Diego Radiological Society• American College of Radiology Imaging Network• ECOG-ACRIN• Society of Breast MRI

Michal Bar-Natan, MD, is Associate Professor of Clinical Medicine and a member of the Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital in New York City. Dr. Bar-Natan graduated cum laude from the Sackler School of Medicine. She completed her Internal Medicine Residency at Sheba Medical Center and her Fellowship in Hematology and Medical Oncology at NYU Langone Health. In addition to her clinical fellowship training, Dr. Bar-Natan completed a research fellowship at Dana Farber Cancer Institute and Brigham and Women’s Hospital (Harvard Medical School) with a focus on the role that signal transducer and activator of transcription (STAT) proteins play in the development and treatment of myeloproliferative neoplasms (MPNs) and leukemias.Prior to this position Dr. Bar-Natan served as Associate Professor of Medicine at the Icahn School of Medicine at Mt. Sinai, an Attending Physician with the Center of Excellence for Blood Cancers and Myeloid Disorders, and as the leader of the Acute Lymphoblastic Leukemia program at the Mt. Sinai Tisch Cancer Institute. Dr. Bar-Natan’s focus is on translational research in malignant hematology, particularly myeloid malignancies and acute lymphoblastic leukemia, and the development of investigator-initiated clinical trials for patients with these conditions. She leads early phase clinical trials implementing new therapeutic approaches, such as immunotherapies and combination therapies, and serves as the PI and co-investigator on many clinical trials for acute leukemias and myeloproliferative neoplasms.